Cablivi
| Cablivi | |
|---|---|
| Term | Cablivi |
| Short definition | Cablivi - (pronounced) (cab-LIH-vee) drug used in conjunction with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Cablivi - (pronounced) (cab-LIH-vee) drug used in conjunction with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. Cablivi attaches to a protein called VWF, which can help prevent blood clots from forming. It's a kind of nanobody (a tiny antibody). Also called caplacizumab
External links
- Medical encyclopedia article on Cablivi
- Wikipedia's article - Cablivi
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski